Gourni E et al. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med, 2011, 52(11):1803-10.
 Wester HJ et al. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Theranostics, 2015, 1;5(6):618-30.
 Herrmann K. et al. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor. J Nucl Med. 2015, 56(3):410-6.
 Walenkamp AM et al. CXCR4 Ligands: The Next Big Hit? J Nucl Med. 2017 58(Suppl 2):77S-82S.
 Ripschler C. et al. Upregulated myocardial CXCR4-expressionafter myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI J Nucl Cardiol. 2016 23(1):131-133
 Lapa C. et al. 68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma, Theranostics. 2016 6(3):428-434
 Tackeray JT. et al. Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction, JACC Cardiovasc Imaging, 2015 8(12):1417-1426
 Vag T. et al. First Experience on Chemokine Receptor CXCR4 Targeted Positron Emission Tomography (PET) Imaging in Patients with Solid Cancers, J Nucl Med, 2016 57(5):741-746